Management

Duke Collier
Chief Executive Officer

Earl M. (Duke) Collier, Jr. is CEO of 480 Biomedical and serves as executive chairman of Arsenal Medical. For many years, Mr. Collier was executive vice president at Genzyme Corporation. He has also served as president of Vitas Healthcare, a partner at the Washington, DC-based law firm of Hogan and Hartson (now Hogan Lovells) and as Deputy Administrator of the Health Care Finance Administration (now CMS) in the Department of Health and Human Services. Mr. Collier sits on the boards of 480 Biomedical, Arsenal Medical, Capricor, Transmedics and Newton-Wellesley Hospital. He earned a Bachelor of Arts at Yale University and received a law degree from the University of Virginia Law School.
 

Maria Palasis, Ph.D.
Executive Vice President and Chief Technology Officer

Prior to joining 480 Biomedical, Dr. Palasis was R&D director at Boston Scientific, where she managed a portfolio of external biotech and medical device investments and was responsible for the development of new convergence products. Dr. Palasis was as an early member of the team that created the TAXUS^® drug-eluting stent, the single most important revenue generator for Boston Scientific at $3B/year. She held a number of positions within Boston Scientific that included strategic planning for the development of advanced combination therapies, managing alliances through clinical trials, and building and directing the company’s centralized infrastructure for the biological testing of drug eluting stent technologies. Maria received her Bachelor of Science and doctorate in chemical engineering from the University of Cincinnati, and she held a postdoctoral fellowship in molecular biology at the University of Cincinnati School of Medicine.

Ray Knox
Vice President, Operations

Prior to joining 480 Biomedical, Mr. Knox was the vice president of quality assurance and clinical quality at Boston Scientific, where he was responsible for the development of quality systems for the clinical organization, re-creation of post-market surveillance processes and development of analytical infrastructure for the successful TAXUS^® product. Mr. Knox has 22 years of experience in the design, development and manufacturing of medical devices with Becton Dickinson, USCI, Medtronic and Boston Scientific. His experience spans large-scale automated manufacturing, highly specialized research and development prototypes, innovative process development, characterization and process validation. Mr. Knox holds a Bachelor’s degree in engineering from University College Dublin and a master’s degree in business administration from Assumption College.